Fundz

4 D Molecular Therapeutics Inc reported raising $7 Million in an initial SEC Form D filing, from an offering of $7 Million

PUBLIC · FDMTAug 13, 2015

Amount Raised

$7 Million

$7 Million sold, per SEC Form D (first sale Aug 13, 2015)

Round Type

Venture

EmeryvilleBiotechnologyHealth CareMedicalGeneticsTherapeutics

Quick answer

4D Molecular Therapeutics raised $7 Million in a funding round, dated August 13, 2015. 4D Molecular Therapeutics is based in Emeryville, California, United States.

How much did 4D Molecular Therapeutics raise?
4D Molecular Therapeutics raised $7 Million in a funding round on August 13, 2015.
What does 4D Molecular Therapeutics do?
4DMT is a late-stage biotechnology company developing durable, disease-targeted genetic medicines designed to transform treatment paradigms and deliver long-lasting benefits to patients.
Where is 4D Molecular Therapeutics based and how big is it?
4D Molecular Therapeutics is based in Emeryville, California, United States.

Source: Fundz verified event record.

Who else raised in Medical and Genetics around the same time

Companies in the same sectors as 4D Molecular Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Wave Life Sciences raised $66M on August 28, 2015.
  • Aethlon Medical raised $6M on July 9, 2015.
  • Corvus Pharmaceuticals, Inc. raised $75M on September 25, 2015.
  • Eximis Surgical raised $270K (Seed) on September 23, 2015.
  • Cartesian Therapeutics, Inc. raised $37M on September 10, 2015.
  • Kailos Genetics, Inc. raised an undisclosed amount on August 26, 2015.

Who to call at 4D Molecular Therapeutics, and when

A new round usually means 4D Molecular Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day 4D Molecular Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 4D Molecular Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 4D Molecular Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

4D Molecular Therapeutics

Location

Emeryville, California, United States

About

4DMT is a late-stage biotechnology company developing durable, disease-targeted genetic medicines designed to transform treatment paradigms and deliver long-lasting benefits to patients. Its lead candidate, 4D-150, aims to become a backbone therapy for blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF agents through a single intravitreal injection, with Phase 3 development underway for wet age-related macular degeneration and a second indication in diabetic macular edema. The company’s second candidate, 4D-710, is the first known genetic medicine to achieve successful aerosol-based delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 4D Molecular Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for 4D Molecular Therapeutics's next move

See what Strategic adds

4D Molecular Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.